These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 23685934
1. Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma. Clark SW, Taylor J, Wang DL, Abramson JS, Batchelor TT. Neurology; 2013 Jul 02; 81(1):93-4. PubMed ID: 23685934 [No Abstract] [Full Text] [Related]
4. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey LE. J Clin Oncol; 2009 Aug 10; 27(23):3861-7. PubMed ID: 19506159 [Abstract] [Full Text] [Related]
5. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F. Neurosurg Focus; 2014 Dec 10; 37(6):E4. PubMed ID: 25434389 [Abstract] [Full Text] [Related]
6. Temozolomide in glioblastoma multiforme of the elderly. Brandes AA, Vastola F, Basso U, Pasetto LM, Ermani M, Berti F, Rotilio A, Amistà P, Scienza R, Monfardini S. Tumori; 2002 Dec 10; 88(1 Suppl 1):S69-70. PubMed ID: 11989929 [No Abstract] [Full Text] [Related]
7. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme. Tan CW, See SJ, Tham CK, Ang AL. Ann Acad Med Singap; 2014 Jun 10; 43(6):334-7. PubMed ID: 25028145 [No Abstract] [Full Text] [Related]
12. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. Chamberlain MC, Chalmers L. J Neurooncol; 2007 Apr 10; 82(2):207-9. PubMed ID: 17019532 [Abstract] [Full Text] [Related]
13. NICE verdict on Temozolomide: where next? Brada M. Br J Cancer; 2002 Feb 12; 86(4):499-500. PubMed ID: 11870526 [Abstract] [Full Text] [Related]
17. New strategies for cancer management: how can temozolomide carrier modifications improve its delivery? Sharma S, Italiya K, Mittal A, Chitkara D. Ther Deliv; 2017 Jul 01; 8(7):475-477. PubMed ID: 28633588 [No Abstract] [Full Text] [Related]
18. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma. Hamilton DA. Cancer Treat Rev; 2006 Oct 01; 32(6):483-6. PubMed ID: 16730911 [No Abstract] [Full Text] [Related]
19. Temozolomide. A new option for high-grade astrocytomas. Schwenka J, Ignoffo RJ. Cancer Pract; 2000 Oct 01; 8(6):311-3. PubMed ID: 11898150 [No Abstract] [Full Text] [Related]
20. Adjuvant temozolomide: how long and how much? Franceschi E, Tosoni A, Brandes AA. Expert Rev Anticancer Ther; 2008 May 01; 8(5):663-5. PubMed ID: 18471038 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]